Clinical Trials Logo

Clinical Trial Summary

This trial will collect tissue oxygenation data via hyperspectral imaging before and after endovascular procedures.


Clinical Trial Description

This will be a nonrandomized, nonblinded, prospective observational study to correlate the results obtained with the traditional measures of success of endovascular revascularization of peripheral arteries for the treatment of chronic limb ischemia; i.e., ABPI, PVR with oxyhemoglobin (OxyHb) and deoxyhemoglobin (DeoxyHb) measurements obtained with a new imaging device manufactured by HyperMed Inc (OxyVu) that uses hyperspectral technology. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT00768495
Study type Observational
Source HyperMed
Contact Kevin Scomacker, PhD
Phone 781-229-5900
Email kschomacker@hypermed-inc.com
Status Recruiting
Phase N/A
Start date October 2008
Completion date December 2009

See also
  Status Clinical Trial Phase
Completed NCT03294902 - Improving Radiological Outcomes in Arterial Disease - A Pilot Evaluation of the Pedra Tissue Perfusion Monitoring System
Active, not recruiting NCT02908035 - Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee (TANGO) Phase 2
Active, not recruiting NCT02479620 - Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Atherectomy (ATX)-Based Revascularization Phase 2
Recruiting NCT02479555 - Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Percutaneous Transluminal Angioplasty Revascularization Phase 2
Not yet recruiting NCT03847597 - Histological and Imaging Assessment of the Structural Characteristics of the Femoro-popliteal Arterial Segment
Recruiting NCT06416644 - The PORTuguese Registry of Supera Supported Femoral-Fopliteal Revascularization (SupPORT Registry) N/A